Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma

Z. Li*, F. Stölzel, K. Onel, M. Sukhanova, M. K. Mirza, K. L. Yap, O. Borinets, R. A. Larson, W. Stock, M. M. Sasaki, L. Joseph, G. Raca

*Corresponding author for this work

Research output: Contribution to journalLetter

16 Scopus citations
Original languageEnglish (US)
Pages (from-to)2113-2116
Number of pages4
JournalLeukemia
Volume29
Issue number10
DOIs
StatePublished - Oct 1 2015

ASJC Scopus subject areas

  • Hematology
  • Cancer Research
  • Anesthesiology and Pain Medicine

Cite this

Li, Z., Stölzel, F., Onel, K., Sukhanova, M., Mirza, M. K., Yap, K. L., Borinets, O., Larson, R. A., Stock, W., Sasaki, M. M., Joseph, L., & Raca, G. (2015). Next-generation sequencing reveals clinically actionable molecular markers in myeloid sarcoma. Leukemia, 29(10), 2113-2116. https://doi.org/10.1038/leu.2015.81